WinstonWınston
Sikarin Public Company Limited logo

Sikarin Public Company Limited

SKR.BK
49
Medical - Care Facilities · Healthcare
Price
8.00 THB
+0.05 (+0.63%)
Market Cap
16.28B THB
Exchange
Stock Exchange of Thailand
Winston Score
49
Winston is serious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 13, 2026 · filings through Mar 31, 2026

Share count rising — dilution

+2.0% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 2.01B (2021) → 2.05B (2025)

Sikarin Public Company Limited is a Thai private hospital operator based in Bangkok, Thailand. It runs Sikarin Hospital, a full-service medical facility offering inpatient and outpatient care, surgery, specialist consultations, and diagnostic services. The hospital primarily serves middle- to upper-income Thai patients as well as medical tourists, mainly from neighboring countries in Southeast Asia.

The company earns money by charging patients for hospital stays, medical procedures, doctor visits, and ancillary services like lab tests and pharmacy sales. It operates within Thailand's private healthcare sector, which benefits from an aging population and growing demand for quality medical care beyond the public system. With a market capitalization of roughly 16 billion Thai baht, Sikarin is a mid-sized player competing against larger hospital groups like Bumrungrad and Bangkok Dusit Medical Services. The key growth driver is rising healthcare spending among Thailand's growing middle class, while the main risk is intense competition from better-resourced hospital networks that can attract top medical talent and international patients more aggressively.

Winston Score History

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
27.0%
Modest — 27.0% gross margin
Operating Margin
11.1%
Modest — 11.1% operating margin
ROCE
1.9%
Weak — 1.9% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-2.0%
Shrinking sales (-2.0% YoY)
EPS YoY
+5.5%
Modest earnings growth (+5.5% YoY)

Single-digit earnings growth — steady but not exciting.

EPS Consistency
2/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
207%
Turns 207% of profit into real cash
FCF Margin
16.4%
Converts sales into free cash efficiently (16.4%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.05
Conservative — low debt load (0.05)
Interest Cover
31.32x
Comfortably covers interest (31.3x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
24.6x
Growth-priced — P/E 24.6

P/E above the market average. People are paying up for expected growth.

P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield
3.13%
Moderate income — 3.13% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend Growth
+32.4%
Dividend growing fast (32.4% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial